Cerebrolysin and IGF-1 LR3 Interaction

Monitor
Researched 90% confidence

Cerebrolysin and IGF-1 LR3 have an interaction requiring monitoring for interaction with 90% confidence. Additive neurotrophic pathway effects. These compounds primarily affect different organ systems.

Compound Profiles

Cerebrolysin

Neuropeptide Preparation | Neurological Recovery

IV/IM administration provides optimal bioavailability and brain penetration of neuropeptides and neurotrophic factors..

Half-life: Minutes (component-dependent; e.g., BDNF ~10 min) Typical dose: 10-50mL depending on indication (stroke/TBI higher doses) cognitive, longevity
View full profile

IGF-1 LR3

Modified Growth Factor Analog | Muscle Growth

Functions as a full IGF-1 receptor agonist activating PI3K/Akt/mTOR and MAPK/ERK pathways. The modifications prevent protein sequestration, maintaining elevated free circulating levels for extended anabolic effects.

Half-life: 20-30 hours Typical dose: 20-100 mcg daily (start low at 20-30 mcg) growth hormone, healing
igf1mtor carcinogenic riskinsulin disrupting
View full profile

Combined Organ Load

Brain
low
Blood Vessels
low
Pituitary
low

Frequently Asked Questions

Can I take Cerebrolysin with IGF-1 LR3?

Yes, but with caution. Additive neurotrophic pathway effects. Regular monitoring is advised.

Is Cerebrolysin and IGF-1 LR3 safe together?

Based on documented research, this combination is considered monitor. No critical safety flags identified for this pair.

What are the interactions between Cerebrolysin and IGF-1 LR3?

Additive neurotrophic pathway effects. This assessment has 90% confidence and is based on documented research data.

How should I time Cerebrolysin and IGF-1 LR3?

Cerebrolysin has a half-life of Minutes (component-dependent; e.g., BDNF ~10 min) and IGF-1 LR3 has a half-life of 20-30 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Cerebrolysin vs IGF-1 LR3

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.